Northwest Biotherapeutics Inc
NWBO- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001072379
No open-market purchases or sales by Northwest Biotherapeutics Inc insiders were filed in the last 90 days; 8 institutions reported holding it in 13F filings for Q2 2026, worth $413.6K in total; no superinvestor holds it.
13F holders, Q3 2024
Institutional positions in Northwest Biotherapeutics Inc as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 11
- −2 vs. Q2 2024
- Shares held
- 656.6K
- −14.5K (−2.2%) vs. Q2 2024
- Total value
- $208.7K
- −$77.5K (−27.1%) vs. Q2 2024
- New holders
- 0
- 1 more added
- Sold out
- 2
- 0 more reduced
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NWBO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 8 | $413.6K |
| Q1 2026 | 8 | $83.3K |
| Q4 2025 | 7 | $43.7K |
| Q3 2025 | 9 | $175.2K |
| Q2 2025 | 9 | $173.5K |
| Q1 2025 | 8 | $160.2K |
| Q4 2024 | 11 | $196.4K |
| Q3 2024 | 11 | $208.7K |
| Q2 2024 | 13 | $286.2K |
| Q1 2024 | 10 | $303.6K |
| Q4 2023 | 10 | $365.1K |
| Q3 2023 | 11 | $481.9K |
| Q2 2023 | 11 | $1.69M |
| Q1 2023 | 14 | $2.01M |
| Q4 2022 | 15 | $2.25M |
| Q3 2022 | 13 | $1.70M |
| Q2 2022 | 14 | $633.1K |
| Q1 2022 | 15 | $603.0K |
| Q4 2021 | 13 | $576.0K |
| Q3 2021 | 10 | $453.0K |
| Q2 2021 | 13 | $577.0K |
| Q1 2021 | 10 | $472.0K |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Northwest Biotherapeutics Inc; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Moloney Securities Asset Management, LLC | 462,215 | $147.9K | 0.02% | +37,905+8.9% | Added |
| Opus Capital Group, LLC | 60,150 | $19.0K | 0.00% | 00.0% | Unchanged |
| Williams Jones Wealth Management, LLC. | 35,000 | $11.2K | 0.00% | 00.0% | Unchanged |
| Ethos Financial Group, LLC | 23,700 | $8.00K | 0.00% | 00.0% | Unchanged |
| MAI Capital Management | 20,000 | $6.40K | 0.00% | 00.0% | Unchanged |
| Lee Danner & Bass Inc | 20,000 | $6.00K | 0.00% | 00.0% | Unchanged |
| AlphaMark Advisors, LLC | 14,007 | $4.00K | 0.00% | 00.0% | Unchanged |
| KLCM Advisors, Inc. | 10,000 | $3.20K | 0.00% | 00.0% | Unchanged |
| Advisors Management Group Inc | 10,270 | $3.00K | 0.00% | 00.0% | Unchanged |
| Hantz Financial Services, Inc. | 250 | $0 | 0.00% | 00.0% | Unchanged |
| Coston, McIsaac & Partners | 1,000 | $0 | 0.00% | 00.0% | Unchanged |
| Maripau Wealth Management LLC | 0 | $0 | 0.00% | −39,493−100.0% | Sold out |
| Sentinus, LLC | 0 | $0 | 0.00% | −12,925−100.0% | Sold out |